“These are real savings that people will see right away,” a senior White House health official said. “This isn’t theoretical — these are price cuts negotiated directly with manufacturers.”
Trump urged Congress to act swiftly to make the reforms permanent. He called on lawmakers to pass his proposed “Great Healthcare Plan,” which would codify Most-Favored-Nation pricing into law, require full price transparency, and allow TrumpRx purchases to be integrated with health insurance coverage.
The Department of Health and Human Services said more than 40 manufacturers have already joined the TrumpRx platform, and more are expected in the coming weeks. Officials said the administration will prioritize adding high-impact treatments for chronic illnesses such as heart disease, asthma, cancer, and autoimmune disorders later this year.
Industry analysts said the program could represent a turning point if major pharmaceutical firms comply with the pricing benchmarks. But they also cautioned that the model’s success will depend on sustained political support and cooperation from Congress.
